Research led by scientists at the University of Toronto and Caprion Pharmaceuticals has uncovered the basis for a diagnostic, immunotherapy and vaccine, providing a way to detect and treat the brain-wasting damage of infectious prions

The age of molecular farming may be the salvation of many Australian farms. [ + ]

On a wall at CSIRO Plant Industry's Merbein laboratories, is an old photo-micrograph of a grapevine floral bud. Dr Nigel Steele Scott, head of Plant Industry's horticultural research laboratories in Glen Osmond, South Australia, says it's his favourite image -- a portent of a revolution in viticulture that is still having an enormous impact on the Australian wine industry today. [ + ]

Australia must act now to establish the pattern of laws, institutions and policies needed to guide us through the age of the 'New Genetics', according to a landmark report into the protection of human genetic information released recently

Filtering different kinds of molecules has always been difficult, but a new process by researchers at the University of Rochester may have paved the way to creating a new kind of membrane with pores so fine they can separate a mixture of gases

FRET microscopy imaging is widely used to detect protein-protein interactions inside living cells. This application note describes the use of one and two-photon FRET and in characterising the dimerisation of C/EBPa protein

Manufacturing processes of pharmaceutical tablets may change the morphology of the crystalline state of the active pharmaceutical ingredients (API) or the excipients

South Australia’s fledgling biotechnology industry has received the first of two shots in the arm with the commissioning of Hydra, a $1.7 million system that is Australia’s third-largest supercomputer and the largest of its type. [ + ]

The consumables market in Australia has long been supported by the lab, mining and agricultural customer. But now, biotech is changing the landscape. Faster moving, smaller and more disposable, consumables are making the move to a technology based market. Jeremy Torr reports [ + ]

Some Australian listed biotechs are trapped in a death spiral. Shareholders are reluctant to top up their original investments, while cash burn rates tip them ever closer to the edge of insolvency. But there are bright spots, writes Pete Young [ + ]

Graeme O'Neill discovers that the biotech community needs a whole new strategy to win points on GM crops [ + ]

Following the launch of Genethon, France decided to invest heavily in investigating the genome of plants and, more recently, animals by means of high-budget programs combining public and private research. The first applications are now starting to appear

La Trobe University physicists have reversed the traditional direction of technology flow by designing and building a highly sophisticated toroidal electron spectrometer and exporting it to Germany

Victoria prides itself as the powerhouse of Australian biotech. But not everything is blooming in the state's biotech garden, writes Graeme O'Neill [ + ]

Locals thank strong government support for helping to boost Victoria's biomedical industry, Melissa Trudinger discovers. [ + ]